Insider buying last 90 days
No open-market insider purchases were filed for ARCC in the last 90 days.
From Form 4 filings, dated to when each was filed.
Nov 13 close
Ares Capital this week centers on its agreement to acquire MidCap Financial Investment (MFIC) for $10.88 per share, made up of $9.67 in ARCC stock and $1.21 in cash, a deal described as adding portfolio diversification and expected to be modestly accretive to core earnings. The move follows ARCC's Q3 NAV return of 2.3%, its strongest in the past year, while coverage also notes MFIC's own Q3 NAV per share decline to $12.86 from $13.37 and net investment income of $0.34 per share. Separate commentary addresses ARCC's dividend coverage and yield profile alongside the deal context.
ARCC trades at $19.35, up 1.2%, sitting above both its 50-day average of $19.15 and 200-day average of $18.97, with the 50-day above the 200-day. The GekkoIndex reads 52.2, placing the stock in the Neutral zone with a five-day change of 1.1. Gekko Fair Value stands at $19.90, putting the current price 2.8% below that level.
The next earnings report is scheduled for 3 February 2027, 85 days out and beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in their respective windows. Analyst coverage from 7 firms shows 5 buy and 2 hold ratings, with a consensus target of $21 implying 8.5% upside. Seasonality over 5 years shows an average 20-day return of 0.3%, positive in 3 of those years.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Ares Capital scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
Above 50 and 200-day
Close $19.17 is above the 50-day ($19.09) and 200-day ($18.95) averages, and the 50-day is above the 200-day.
See the chart56.1, Neutral
Reading 56.1 is in the Neutral zone.
See the GekkoIndex3.4% below
Price is within 5% of Gekko Fair Value (3.4% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 80 days
Next report Feb 3, 2027, 80 days away — outside a typical 20-trading-day hold.
See earnings+0.1% on average
From this point in the calendar, the next 20 trading days averaged +0.1% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Ares Capital closed at $19.17 on Nov 13, 2026, −5.9% over the past year, inside a 52-week range of $17.40 to $21.14.
Use the left and right arrow keys to read daily values.
Put ARCC on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Ares Capital provides financing to middle-market companies, structuring deals such as acquisitions, recapitalizations, leveraged buyouts and corporate restructurings. It also supplies mezzanine debt, rescue financing, growth capital and refinancing arrangements. Its focus tends toward sectors including manufacturing, business services, consumer products, healthcare and information technology services, with occasional interest in restaurants, retail, oil and gas, and wider technology ventures.
The firm works through regional offices across the United States, with its New York base handling the Northeast, Mid-Atlantic, Southeast and Southwest, a Chicago office covering the Midwest, and a Los Angeles office addressing the Western region. Investments generally range from twenty million to two hundred million dollars, occasionally reaching as high as four hundred million, directed at companies with EBITDA between ten million and two hundred fifty million dollars, while debt placements typically run from ten million to one hundred million dollars. Ares Capital uses instruments such as credit facilities, lien loans, unitranche structures, subordinated debt and selective equity positions, often taking a lead or agent role and seeking board representation in the companies it finances.
Ares Capital's shares are listed on the NASDAQ under the ticker ARCC.
Ares Capital’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 56.1, in the Neutral zone, up 2.9 points over five sessions.
Up 2.9 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 39 | +0.5% | +0.1% | ||
| Accumulation | 227 | +0.4% | +0.4% | ||
| Neutral (current zone) | 407 | −0.2% | −0.3% | ||
| Distribution | 20 | −0.5% | −1.4% | ||
| Selling | 9 | Too few readings yet | |||
Average ARCC share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Ares Capital trades 3.4% below Gekko Fair Value of $19.85, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Ares Capital shares are worth, recalculated every trading day.
$19.85
Gekko Fair Value, Nov 14, 2026
3.4% below fair value · About fair value
At the end of Aug 2026 the price was 0.1% below the estimate.
No open-market insider purchases were filed for Ares Capital, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ARCC in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ARCC were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Ares Capital has been buying back its own shares.
From company filings.
0of the funds Gekko tracks hold ARCC.
Ares Capital reports on Feb 3, 2027 (80 days away), and beat the EPS estimate in 1 of its last 8 reports.
Feb 3, 2027
80 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $0.47 est $0.47 | $768.0M est $770.2M | −1.1% |
| Apr 28, 2026 | $0.47 est $0.48 | $763.0M est $778.0M | +0.3% |
| Feb 4, 2026 | $0.50 est $0.50 | $793.0M est $793.0M | −1.8% |
| Oct 28, 2025 | $0.50 est $0.50 | $655.0M est $768.1M | +1.4% |
| Jul 29, 2025 | $0.50 est $0.51 | $579.0M est $748.8M | −0.3% |
| Apr 29, 2025 | $0.50 est $0.53 | $446.0M est $763.6M | −2.8% |
| Feb 5, 2025 | $0.55 est $0.58 | $759.0M est $785.4M | −4.5% |
| Oct 30, 2024 | $0.58 est $0.60 | $613.0M est $770.4M | −2.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Ares Capital is $21.00, +9.5% from the last close, from 7 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 7 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 11 | UBS | $21 | +9.5% |
| Oct 29 | UBS | $21 | +9.5% |
| Oct 29 | KBW | $20 | +4.3% |
| Oct 28 | RBC Capital | $21 | +9.5% |
| Oct 28 | B. Riley Securities | $20 | +4.3% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Ares Capital averaged +0.1% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.3% | 2 of 5 |
| Next 10 trading days | +0.3% | 3 of 5 |
| Next 15 trading days | +0.5% | 2 of 5 |
| Next 20 trading days | +0.1% | 3 of 5 |
| Next 30 trading days | −0.1% | 4 of 5 |
For scale, ARCC’s typical 20-trading-day move in either direction is about 2.9%.
Ares Capital’s market cap is $13.84B, with a P/E ratio of 15.7 and revenue of $3.09B over the last twelve months.
2 headlines about Ares Capital from the past week, newest first, each linking to the publisher.
Ares Capital’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MSMorgan Stanley | Neutral | 4.8% below |
| BLKBlackRock | Neutral | 0.9% above |
| UBSUBS | Neutral | 6.2% below |
| BXBlackstone | Neutral | 5.3% below |
| BNBrookfield | Neutral | 8.7% below |
| KKRKKR | Neutral | 7.1% below |
A peer links to its own page where one exists.
Ares Capital’s market cap is $13.84B at the Nov 13, 2026 close of $19.17, with 722.2M shares outstanding. The shares trade on a P/E ratio of 15.7.
The consensus analyst 12-month price target for Ares Capital is $21.00, +9.5% from the last close. Of the 7 firms that rated the stock in the last 90 days, 5 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Ares Capital is about fair value: the Nov 13, 2026 close of $19.17 is 3.4% below Gekko Fair Value of $19.85. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Ares Capital is expected to report on Feb 3, 2027 (80 days away). Analysts expect earnings of $0.47 per share on revenue of $781.3M. Ares Capital beat the earnings estimate in 1 of its last 8 reports, moving 1.8% on average across the report.
Ares Capital’s 52-week high is $21.14 and its 52-week low is $17.40; it closed at $19.17 on Nov 13, 2026, −5.9% over the past year. Over the last five years the shares peaked at $23.84 on Feb 3, 2025.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.